400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / NADPH Oxidase / 2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
CAS No.: 1218942-37-0
Synonyms: GKT137831;GKT831;GTK-831
GKT137831 is a specific dual Nox1/Nox4 inhibitor with Ki of 140±40 nM and 110±30 nM and a potent inhibitor of fibrosis and hepatocyte apoptosis.
生物活性
靶点 | NADPH Oxidase 1 Ki:140±40nM | NADPH Oxidase 4 Ki:110±30nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03740217 | Phase 1 | Phase 1 | Not yet recruiting | April 15, 2019 | - |
NCT03226067 | Primary Biliary Cirrhosis | Phase 2 | Active, not recruiting | September 26, 2019 | - |
NCT02010242 | Type 2 Diabetes Mellitus With ... more >>Diabetic Nephropathy Collapse << | Phase 2 | Completed | - | - |
实验方案
技术信息
CAS号 | 1218942-37-0 | 储存条件 |
|
|||||||||||
分子式 | C21H19ClN4O2 | 运输 | 蓝冰 | |||||||||||
分子量 | 394.85 | 别名 | GKT137831;GKT831;GTK-831 | |||||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03740217 | Phase 1 | Phase 1 | Not yet recruiting | April 15, 2019 | - |
NCT03226067 | Primary Biliary Cirrhosis | Phase 2 | Active, not recruiting | September 26, 2019 | - |
NCT02010242 | Type 2 Diabetes Mellitus With ... more >>Diabetic Nephropathy Collapse << | Phase 2 | Completed | - | - |
靶点 | Description | IC50 |
---|---|---|
NADPH Oxidase 1 | Ki:140±40nM | |
NADPH Oxidase 4 | Ki:110±30nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网